株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

アフェレシスの世界市場予測 〜2021年:製品、処置、アプリケーションおよび技術別分析

Apheresis Market by Product (Plasma & Component Separator, Hemoperfusion, Disposable), Procedure (Therapeutic, Photopheresis, Donor), Application (Plasmapheresis, Plateletpheresis), Technology (Centrifuge, Membrane Separation) - Global Forecast to 2021

発行 MarketsandMarkets 商品コード 259318
出版日 ページ情報 英文 215 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.24円で換算しております。
Back to Top
アフェレシスの世界市場予測 〜2021年:製品、処置、アプリケーションおよび技術別分析 Apheresis Market by Product (Plasma & Component Separator, Hemoperfusion, Disposable), Procedure (Therapeutic, Photopheresis, Donor), Application (Plasmapheresis, Plateletpheresis), Technology (Centrifuge, Membrane Separation) - Global Forecast to 2021
出版日: 2017年02月20日 ページ情報: 英文 215 Pages
概要

アフェレシスは、医療機器を通して血液を成分ごとに分け、ある成分を取り除いたり残したりした状態で患者に戻すという治療のプロセスです。世界のアフェレシス市場は、2016年から2021年にかけてCAGR7.7%の規模で成長し、2021年には20億6,000万米ドルに達する見込みです。その成長は慢性疾患の有病率の上昇および複雑な手術の増加が背景にあります。同様に、臓器移植の施術数の増加も市場の成長を支えています。

当レポートでは、アフェレシス市場の動向について調査分析を行い、市場の概要、処置別、製品種類別、技術別、アプリケーション別に考察するとともに、地域別分析、競合状況などについて考察した結果をまとめております。

第1章 イントロダクション

  • 調査目的
  • 市場定義
  • 対象市場
  • 通貨
  • 調査上の制約
  • ステークホルダー

第2章 調査方法

  • 調査データ
    • 2次データ
    • 1次データ
  • 市場規模予測
  • 市場内訳およびデータの三角分析
  • 市場シェア予測
    • 調査の前提条件

第3章 エグゼクティブサマリー

第4章 重要な考察

  • 市場概要
  • アジア太平洋地域市場:アプリケーション別
  • 地理別市場概要
  • 地理構成
  • 発展途上市場と先進国市場

第5章 市場概要

  • イントロダクション
  • 市場のダイナミクス
    • 市場成長促進因子
    • 抑制因子
    • 機会
    • 課題

第6章 産業分析

  • イントロダクション
  • 産業動向
  • ポーターのファイブフォース分析
  • ベンダーのベンチマーキング
  • 規制分析
    • 北米
    • 欧州
    • アジア太平洋地域

第7章 アフェレシスの世界市場:処置別

  • イントロダクション
  • 自動/アフェレシス血液採取(ドナーアフェレシス)
  • 治療アフェレシス
    • 疾患別
    • 処置別

第8章 世界のアフェレシス市場:製品別

  • イントロダクション
  • デバイス
  • 消耗品

第9章 世界のアフェレシス市場:技術別

  • イントロダクション
  • 遠心分離
  • 膜分離

第10章 世界のアフェレシス市場:アプリケーション別

  • イントロダクション
  • プラズマフェレシス
  • 血小板フェレシス
  • 赤血球アフェレシス
  • 白血球アフェレシス
  • その他

第11章 地域分析

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ地域

第12章 競合状況

  • 概要
  • 市場シェア分析
  • 競業状況および動向
  • 契約、提携、協事
  • M&A
  • 拡大
  • 新製品の発売
  • その他の戦略

第13章 企業プロファイル

  • イントロダクション
  • CERUS CORPORATION
    • 企業概要
    • 製品・サービス
    • 戦略・分析
    • 発展動向
    • MnMの見解など
  • FRESENIUS SE & CO. KGAA
  • 旭化成メディカル (旭化成の子会社)
  • HAEMONETICS CORPORATION
  • TERUMO BCT, INC.
  • HEMACARE CORPORATION
  • B. BRAUN MELSUNGEN AG
  • カネカ
  • 川澄化学
  • 日機装

第14章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: MD 1407

The global apheresis market is projected to reach USD 2.06 billion by 2021, at a CAGR of 7.7% during the forecast period of 2016 to 2021. Growth in this market is majorly driven by the rising prevalence of chronic diseases and growing number of complex surgeries. Similarly, the increasing number of organ transplant procedures also supports the growth of the market.

In this report, the market is segmented by product, procedure, technology, application, and region. Based on technology, the market is mainly segmented into centrifugation and membrane separation technologies. The centrifugation technology segment accounted for the largest share in 2015. This segment is also projected to register the highest growth during the forecast period. The large share and high growth in this market can be attributed to the advantages offered by centrifugation over membrane separation. Centrifugation is used for the apheresis of any blood component, whereas the use of membrane separation is limited to plasma collection and plasma exchange, and it cannot remove cellular elements.

Based on application, the market is segmented into plasmapheresis, plateletpheresis, erythrocytapheresis, leukapheresis, and other applications. In 2015, the plasmapheresis segment accounted for the largest share of the market. Growth in the plasmapheresis segment can be attributed to the increasing use of plasma fractionation products in the treatment of various diseases and the growing demand for plasma and its components from pharmaceutical and biopharmaceutical companies.

In 2015, North America commanded the largest share of the market, followed by Europe. The U.S. is a prime market for apheresis due to greater accessibility to advanced blood collection technologies and presence of a well-established healthcare infrastructure in the country. The Asia-Pacific market is expected to witness the highest growth in the coming years primarily due to the growing focus of manufacturers in this region.

Major players in the global apheresis market are Haemonetics Corporation (U.S.), Fresenius Medical Care (Germany), Terumo BCT, Inc. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Kawasumi Laboratories Inc. (Japan), Cerus Corporation (U.S.), B. Braun Melsungen AG (Germany), HemaCare Corporation (U.S.), Kaneka Corporation (Japan), and Nikkiso Co., Ltd. (Japan).

Research Coverage:

  • Detailed insights on all the submarkets, based on application (plasmapheresis, plateletpheresis, erythrocytapheresis, leukapheresis, and other applications), this can help market players to identify high growth segments in the apheresis market.
  • The report also provides information on key players in this market and their growth strategies and recent developments. This can help the company to assess the competition at global and regional levels in a better manner.
  • Key insights and market sizing for the different therapeutic procedures of the apheresis market, namely, therapeutic plasma exchange (TPE), therapeutic cytapheresis, photopheresis, and extracorporeal immunoadsorption (ECI).
  • Country-wise market size and forecast for all the subsegments. Thus, not only the high growth product, procedure, technology, and application; the market size numbers provided in the report will also enable market players to identify key geographic markets, and thereby strategize global marketing efforts to achieve sustainable revenue growth in the coming years.
  • It provides key insights on market dynamics, such as drivers, restraints, opportunities, and challenges for this market.

Reasons to Buy the Report:

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater market share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies to increase market shares.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by top players in the apheresis market. The report analyzes the market by product type across all regions
  • Product Development/Innovation: Detailed insights on upcoming trends, R&D activities, and product launches in the apheresis market
  • Market Development: Comprehensive information on lucrative emerging markets, based on product, procedure, technology, application, and region
  • Market Diversification: Exhaustive information about new products, growing regions, recent developments, and investments in the apheresis market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, and manufacturing capabilities of leading players in the apheresis market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Key industry insights
  • 2.2. MARKET SIZE ESTIMATION
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. MARKET SHARE ESTIMATION
    • 2.4.1. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. APHERESIS: MARKET OVERVIEW
  • 4.2. ASIA-PACIFIC: APHERESIS MARKET, BY APPLICATION
  • 4.3. GEOGRAPHIC SNAPSHOT OF THE APHERESIS MARKET
  • 4.4. GEOGRAPHIC MIX: APHERESIS MARKET
  • 4.5. APHERESIS MARKET: DEVELOPING VS. DEVELOPED MARKETS

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. MARKET DRIVERS
      • 5.2.1.1. Rising prevalence of diseases and growing number of trauma and injury cases
      • 5.2.1.2. Increasing demand for source plasma from biopharmaceutical companies
      • 5.2.1.3. Rising demand for blood components and growing concerns regarding blood safety
      • 5.2.1.4. Increase in the number of complex surgical procedures
      • 5.2.1.5. Favorable reimbursement policies for apheresis procedures
    • 5.2.2. MARKET RESTRAINTS
      • 5.2.2.1. Lack of awareness about apheresis procedures
      • 5.2.2.2. High cost of apheresis devices and procedures
      • 5.2.2.3. Scarcity of qualified donors
    • 5.2.3. MARKET OPPORTUNITIES
      • 5.2.3.1. Extending the reach of apheresis in the untapped pediatric segment
      • 5.2.3.2. Emerging economies with increasing investments from government bodies and leading players
    • 5.2.4. MARKET CHALLENGES
      • 5.2.4.1. Recruitment of voluntary non-remunerated donors
      • 5.2.4.2. Blood transfusion safety in developing countries

6. INDUSTRY INSIGHTS

  • 6.1. INTRODUCTION
  • 6.2. INDUSTRY TRENDS
    • 6.2.1. NEW INDICATIONS FOR PLASMA PRODUCTS
    • 6.2.2. GROWING NUMBER OF AGREEMENTS AND PARTNERSHIPS
  • 6.3. PORTER'S FIVE FORCE ANALYSIS
    • 6.3.1. THREAT OF NEW ENTRANTS
    • 6.3.2. THREAT OF SUBSTITUTES
    • 6.3.3. BARGAINING POWER OF SUPPLIERS
    • 6.3.4. BARGAINING POWER OF BUYERS
    • 6.3.5. INTENSITY OF COMPETITIVE RIVALRY
  • 6.4. VENDOR BENCHMARKING
    • 6.4.1. PRODUCT PORTFOLIO ANALYSIS: APHERESIS MARKET
  • 6.5. REGULATORY ANALYSIS
    • 6.5.1. NORTH AMERICA
      • 6.5.1.1. U.S.
      • 6.5.1.2. Canada
    • 6.5.2. EUROPE
    • 6.5.3. ASIA-PACIFIC
      • 6.5.3.1. Japan
      • 6.5.3.2. China
      • 6.5.3.3. India 60 

7. GLOBAL APHERESIS MARKET, BY PROCEDURE

  • 7.1. INTRODUCTION
  • 7.2. AUTOMATED/APHERESIS BLOOD COLLECTION (DONOR APHERESIS)
  • 7.3. THERAPEUTIC APHERESIS
    • 7.3.1. THERAPEUTIC APHERESIS MARKET, BY DISEASE
      • 7.3.1.1. Neurological Disorders
      • 7.3.1.2. Blood Disorders
      • 7.3.1.3. Cardiovascular Disorders
      • 7.3.1.4. Renal Disorders
      • 7.3.1.5. Autoimmune Disorders
      • 7.3.1.6. Metabolic Disorders
      • 7.3.1.7. Other Disorders
    • 7.3.2. THERAPEUTIC APHERESIS MARKET, BY PROCEDURE
      • 7.3.2.1. Therapeutic Plasma Exchange (TPE)
      • 7.3.2.2. Therapeutic Cytapheresis
        • 7.3.2.2.1. Therapeutic Erythrocytapheresis
        • 7.3.2.2.2. Therapeutic Plateletphersis
        • 7.3.2.2.3. Leukapheresis
      • 7.3.2.3. Photopheresis
      • 7.3.2.4. Extracorporeal Immunoadsorption (ECI)

8. GLOBAL APHERESIS MARKET, BY PRODUCT

  • 8.1. INTRODUCTION
  • 8.2. APHERESIS DEVICES
    • 8.2.1. PLASMA SEPARATORS
    • 8.2.2. PLASMA COMPONENT SEPARATORS
    • 8.2.3. IMMUNOADSORPTION COLUMNS
    • 8.2.4. PLASMA PERFUSION COLUMNS
    • 8.2.5. HEMOPERFUSION COLUMNS
  • 8.3. APHERESIS DISPOSABLES

9. GLOBAL APHERESIS MARKET, BY TECHNOLOGY

  • 9.1. INTRODUCTION
  • 9.2. CENTRIFUGATION
    • 9.2.1. INTERMITTENT FLOW
    • 9.2.2. CONTINUOUS FLOW
  • 9.3. MEMBRANE SEPARATION 103 

10. GLOBAL APHERESIS MARKET, BY APPLICATION

  • 10.1. INTRODUCTION
  • 10.2. PLASMAPHERESIS
  • 10.3. PLATELETPHERESIS
  • 10.4. ERYTHROCYTAPHERESIS
  • 10.5. LEUKAPHERESIS
  • 10.6. OTHER APPLICATIONS

11. APHERESIS MARKET, BY REGION

  • 11.1. INTRODUCTION
  • 11.2. NORTH AMERICA
    • 11.2.1. U.S.
    • 11.2.2. CANADA
  • 11.3. EUROPE
    • 11.3.1. GERMANY
    • 11.3.2. FRANCE
    • 11.3.3. U.K.
    • 11.3.4. ITALY
    • 11.3.5. SPAIN
    • 11.3.6. REST OF EUROPE (ROE)
  • 11.4. ASIA-PACIFIC (APAC)
    • 11.4.1. JAPAN
    • 11.4.2. CHINA
    • 11.4.3. INDIA
    • 11.4.4. REST OF ASIA-PACIFIC (ROAPAC)
  • 11.5. LATIN AMERICA
    • 11.5.1. BRAZIL
    • 11.5.2. MEXICO
    • 11.5.3. REST OF LATIN AMERICA (ROLA)
  • 11.6. MIDDLE EAST AND AFRICA

12. COMPETITIVE LANDSCAPE

  • 12.1. OVERVIEW
  • 12.2. MARKET SHARE ANALYSIS
  • 12.3. COMPETITIVE SITUATION AND TRENDS
  • 12.4. AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
  • 12.5. MERGERS AND ACQUISITIONS
  • 12.6. EXPANSIONS
  • 12.7. PRODUCT LAUNCHES
  • 12.8. OTHER STRATEGIES

13. COMPANY PROFILES (Overview, Products & Services, Strategies & Insights, Developments and MnM View)*

  • 13.1. INTRODUCTION
  • 13.2. CERUS CORPORATION
  • 13.3. FRESENIUS SE & CO. KGAA
  • 13.4. ASAHI KASEI MEDICAL CO., LTD. (A SUBSIDIARY OF ASAHI KASEI CORPORATION)
  • 13.5. HAEMONETICS CORPORATION
  • 13.6. TERUMO BCT, INC.
  • 13.7. HEMACARE CORPORATION
  • 13.8. B. BRAUN MELSUNGEN AG
  • 13.9. KANEKA CORPORATION
  • 13.10. KAWASUMI LABORATORIES INC.
  • 13.11. NIKKISO CO., LTD.

*Details on Overview, Products & Services, Strategies & Insights, Developments and MnM View might not be captured in case of unlisted companies.

14. APPENDIX

  • 14.1. INSIGHTS OF INDUSTRY EXPERTS
  • 14.2. DISCUSSION GUIDE
  • 14.3. OTHER DEVELOPMENTS
  • 14.4. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.5. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 14.6. AVAILABLE CUSTOMIZATIONS
  • 14.7. RELATED REPORTS
  • 14.8. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: GLOBAL APHERESIS MARKET SNAPSHOT
  • TABLE 2: INCREASING DEMAND FOR SOURCE PLASMA FROM BIOPHARMACEUTICAL COMPANIES TO DRIVE MARKET GROWTH
  • TABLE 3: REQUIRED UNITS OF BLOOD AND BLOOD COMPONENTS, BY TYPE OF SURGERY
  • TABLE 4: U.S.: PAYMENT RATES FOR APHERESIS PROCEDURES FOR THE YEAR 2016 & 2017
  • TABLE 5: LACK OF AWARENESS & CHALLENGES IN DONOR RECRUITMENT TO RESTRICT MARKET GROWTH
  • TABLE 6: FREQUENCY OF BLOOD DONATIONS FROM HEALTHY DONORS
  • TABLE 7: EXTENDING THE REACH OF APHERESIS IN THE UNTAPPED PEDIATRIC SEGMENT OFFERS SIGNIFICANT GROWTH OPPORTUNITIES
  • TABLE 8: RECRUITMENT OF VOLUNTARY NON-REMUNERATED DONORS IS A MAJOR CHALLENGE IN THE MARKET
  • TABLE 9: GLOBAL APHERESIS MARKET SIZE, BY PROCEDURE, 2014-2021 (USD MILLION)
  • TABLE 10: GLOBAL APHERESIS MARKET SIZE FOR AUTOMATED BLOOD COLLECTION, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 11: GLOBAL THERAPEUTIC APHERESIS MARKET SIZE, BY COUNTRY, 2014-2021, (USD MILLION)
  • TABLE 12: GLOBAL ESTIMATED DISABILITY-ADJUSTED LIFE YEARS (DALYS), BY DISEASE, 2015-2030 (POPULATION IN 000')
  • TABLE 13: GLOBAL THERAPEUTIC APHERESIS MARKET SIZE, BY DISEASE, 2014-2021, (USD MILLION)
  • TABLE 14: NEUROLOGICAL DISORDERS: ESTIMATED DALYS BY REGION, 2015-2030 (000')
  • TABLE 15: NEUROLOGICAL DISEASES/DISORDERS TREATED BY THERAPEUTIC APHERESIS
  • TABLE 16: GLOBAL APHERESIS MARKET SIZE FOR NEUROLOGICAL DISORDERS, BY COUNTRY, 2014-2021, (USD MILLION)
  • TABLE 17: GLOBAL APHERESIS MARKET SIZE FOR BLOOD DISORDERS, BY COUNTRY, 2014-2021, (USD MILLION)
  • TABLE 18: CARDIOVASCULAR DISORDERS: ESTIMATED DALYS, BY REGION, 2015-2030 (000')
  • TABLE 19: GLOBAL APHERESIS MARKET SIZE FOR CARDIOVASCULAR DISORDERS, BY COUNTRY, 2014-2021, (USD MILLION)
  • TABLE 20: GLOBAL APHERESIS MARKET SIZE FOR RENAL DISORDERS, BY COUNTRY, 2014-2021, (USD MILLION)
  • TABLE 21: GLOBAL APHERESIS MARKET SIZE FOR AUTOIMMUNE DISORDERS, BY COUNTRY, 2014-2021, (USD MILLION)
  • TABLE 22: DIGESTIVE DISORDERS: ESTIMATED DALYS BY REGION, 2015-2030 (000')
  • TABLE 23: GLOBAL APHERESIS MARKET SIZE FOR METABOLIC DISORDERS, BY COUNTRY, 2014-2021, (USD MILLION)
  • TABLE 24: RHEUMATOID ARTHRITIS: ESTIMATED DALYS BY REGION, 2015-2030 (000')
  • TABLE 25: GLOBAL APHERESIS MARKET SIZE, FOR OTHER DISORDERS, BY COUNTRY, 2014-2021, (USD MILLION)
  • TABLE 26: GLOBAL THERAPEUTIC APHERESIS MARKET SIZE, BY PROCEDURE, 2014-2021, (USD MILLION)
  • TABLE 27: GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2014-2021, (USD MILLION)
  • TABLE 28: GLOBAL THERAPEUTIC CYTAPHERESIS MARKET SIZE, BY COUNTRY, 2014-2021, (USD MILLION)
  • TABLE 29: GLOBAL THERAPEUTIC CYTAPHERESIS MARKET SIZE, BY PROCEDURE, 2014-2021, (USD MILLION)
  • TABLE 30: GLOBAL THERAPEUTIC ERYTHROCYTAPHERESIS DEVICES MARKET SIZE, BY COUNTRY, 2014-2021, (USD MILLION)
  • TABLE 31: GLOBAL THERAPEUTIC PLATELETPHERESIS MARKET SIZE, BY COUNTRY, 2014-2021, (USD MILLION)
  • TABLE 32: LEUKEMIA: ESTIMATED DALYS BY REGION, 2015-2030 (000')
  • TABLE 33: GLOBAL LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 34: GLOBAL PHOTOPHERESIS MARKET SIZE, BY COUNTRY, 2014-2021, (USD MILLION)
  • TABLE 35: GLOBAL EXTRACORPOREAL IMMUNOADSORPTION MARKET SIZE, BY COUNTRY, 2014-2021, (USD MILLION)
  • TABLE 36: GLOBAL APHERESIS MARKET, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 37: APHERESIS DEVICES/SYSTEMS IN THE MARKET
  • TABLE 38: GLOBAL APHERESIS DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 39: GLOBAL APHERESIS DEVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 40: GLOBAL PLASMA SEPARATORS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 41: GLOBAL PLASMA COMPONENT SEPARATORS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 42: GLOBAL IMMUNOADSORPTION COLUMNS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 43: GLOBAL PLASMA PERFUSION COLUMNS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 44: GLOBAL HEMOPERFUSION COLUMNS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 45: GLOBAL APHERESIS DISPOSABLES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 46: GLOBAL APHERESIS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 47: CENTRIFUGATION-BASED APHERESIS DEVICES
  • TABLE 48: GLOBAL CENTRIFUGATION MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 49: GLOBAL CENTRIFUGATION MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 50: GLOBAL INTERMITTENT FLOW MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 51: GLOBAL CONTINUOUS FLOW MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 52: SIZE OF BLOOD COMPONENTS
  • TABLE 53: MEMBRANE SEPARATION-BASED APHERESIS DEVICES
  • TABLE 54: GLOBAL MEMBRANE SEPARATION MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 55: GLOBAL APHERESIS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 56: TOTAL SOURCE PLASMA COLLECTION IN THE U.S. & EUROPE, 2006-2015 (THOUSAND LITERS)
  • TABLE 57: GLOBAL APHERESIS MARKET SIZE FOR PLASMAPHERESIS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 58: GLOBAL APHERESIS MARKET SIZE FOR PLATELETPHERESIS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 59: GLOBAL APHERESIS MARKET SIZE FOR ERYTHROCYTAPHERESIS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 60: GLOBAL APHERESIS MARKET SIZE FOR LEUKAPHERESIS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 61: GLOBAL APHERESIS MARKET SIZE FOR OTHER APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 62: GLOBAL APHERESIS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 63: GLOBAL APHERESIS MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 64: NORTH AMERICA: TOTAL HEMOPHILIA PATIENTS, 2013 VS. 2014 VS. 2015
  • TABLE 65: NORTH AMERICA: APHERESIS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 66: NORTH AMERICA: APHERESIS MARKET SIZE, BY PROCEDURE, 2014-2021 (USD MILLION)
  • TABLE 67: NORTH AMERICA: APHERESIS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 68: NORTH AMERICA: APHERESIS MARKET SIZE, BY DEVICE TYPE, 2014-2021 (USD MILLION)
  • TABLE 69: NORTH AMERICA: APHERESIS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 70: NORTH AMERICA: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 71: U.S.: APHERESIS MARKET SIZE, BY PROCEDURE, 2014-2021 (USD MILLION)
  • TABLE 72: U.S.: APHERESIS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 73: U.S.: APHERESIS MARKET SIZE, BY DEVICE TYPE, 2014-2021 (USD MILLION)
  • TABLE 74: U.S.: APHERESIS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 75: U.S.: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 76: CANADA: APHERESIS MARKET SIZE, BY PROCEDURE, 2014-2021 (USD MILLION)
  • TABLE 77: CANADA: APHERESIS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 78: CANADA: APHERESIS MARKET SIZE, BY DEVICE TYPE, 2014-2021 (USD MILLION)
  • TABLE 79: CANADA: APHERESIS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 80: CANADA: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 81: EUROPE: APHERESIS MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 82: EUROPE: APHERESIS MARKET SIZE, BY PROCEDURE, 2014-2021 (USD MILLION)
  • TABLE 83: EUROPE: APHERESIS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 84: EUROPE: APHERESIS MARKET SIZE, BY DEVICE TYPE, 2014-2021 (USD MILLION)
  • TABLE 85: EUROPE: APHERESIS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 86: EUROPE: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 87: GERMANY: APHERESIS MARKET SIZE, BY PROCEDURE, 2014-2021 (USD MILLION)
  • TABLE 88: GERMANY: APHERESIS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 89: GERMANY: APHERESIS MARKET SIZE, BY DEVICE TYPE, 2014-2021 (USD MILLION)
  • TABLE 90: GERMANY: APHERESIS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 91: GERMANY: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 92: FRANCE: APHERESIS MARKET SIZE, BY PROCEDURE, 2014-2021 (USD MILLION)
  • TABLE 93: FRANCE: APHERESIS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 94: FRANCE: APHERESIS MARKET SIZE, BY DEVICE TYPE, 2014-2021 (USD MILLION)
  • TABLE 95: FRANCE: APHERESIS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 96: FRANCE: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 97: U.K.: APHERESIS MARKET SIZE, BY PROCEDURE, 2014-2021 (USD MILLION)
  • TABLE 98: U.K.: APHERESIS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 99: U.K.: APHERESIS MARKET SIZE, BY DEVICE TYPE, 2014-2021 (USD MILLION)
  • TABLE 100: U.K.: APHERESIS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 101: U.K.: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 102: ITALY: APHERESIS MARKET SIZE, BY PROCEDURE, 2014-2021 (USD MILLION)
  • TABLE 103: ITALY: APHERESIS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 104: ITALY: APHERESIS MARKET SIZE, BY DEVICE TYPE, 2014-2021 (USD MILLION)
  • TABLE 105: ITALY: APHERESIS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 106: ITALY: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 107: SPAIN: APHERESIS MARKET SIZE, BY PROCEDURE, 2014-2021 (USD MILLION)
  • TABLE 108: SPAIN: APHERESIS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 109: SPAIN: APHERESIS MARKET SIZE, BY DEVICE TYPE, 2014-2021 (USD MILLION)
  • TABLE 110: SPAIN: APHERESIS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 111: SPAIN: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 112: ROE: APHERESIS MARKET SIZE, BY PROCEDURE, 2014-2021 (USD MILLION)
  • TABLE 113: ROE: APHERESIS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 114: ROE: APHERESIS MARKET SIZE, BY DEVICE TYPE, 2014-2021 (USD MILLION)
  • TABLE 115: ROE: APHERESIS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 116: ROE: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 117: APAC: APHERESIS MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 118: APAC: APHERESIS MARKET SIZE, BY PROCEDURE, 2014-2021 (USD MILLION)
  • TABLE 119: APAC: APHERESIS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 120: APAC: APHERESIS MARKET SIZE, BY DEVICE TYPE, 2014-2021 (USD MILLION)
  • TABLE 121: APAC: APHERESIS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 122: APAC: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 123: JAPAN: APHERESIS MARKET SIZE, BY PROCEDURE, 2014-2021 (USD MILLION)
  • TABLE 124: JAPAN: APHERESIS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 125: JAPAN: APHERESIS MARKET SIZE, BY DEVICE TYPE, 2014-2021 (USD MILLION)
  • TABLE 126: JAPAN: APHERESIS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 127: JAPAN: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 128: CHINA: APHERESIS MARKET SIZE, BY PROCEDURE, 2014-2021 (USD MILLION)
  • TABLE 129: CHINA: APHERESIS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 130: CHINA: APHERESIS MARKET SIZE, BY DEVICE TYPE, 2014-2021 (USD MILLION)
  • TABLE 131: CHINA: APHERESIS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 132: CHINA: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 133: INDIA: APHERESIS MARKET SIZE, BY PROCEDURE, 2014-2021 (USD MILLION)
  • TABLE 134: INDIA: APHERESIS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 135: INDIA: APHERESIS MARKET SIZE, BY DEVICE TYPE, 2014-2021 (USD MILLION)
  • TABLE 136: INDIA: APHERESIS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 137: INDIA: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 138: ROAPAC: APHERESIS MARKET SIZE, BY PROCEDURE, 2014-2021 (USD MILLION)
  • TABLE 139: ROAPAC: APHERESIS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 140: ROAPAC: APHERESIS MARKET SIZE, BY DEVICE TYPE, 2014-2021 (USD MILLION)
  • TABLE 141: ROAPAC: APHERESIS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 142: ROAPAC: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 143: LATIN AMERICA: APHERESIS MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 144: LATIN AMERICA: APHERESIS MARKET SIZE, BY PROCEDURE, 2014-2021 (USD MILLION)
  • TABLE 145: LATIN AMERICA: APHERESIS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 146: LATIN AMERICA: APHERESIS MARKET SIZE, BY DEVICE TYPE, 2014-2021 (USD MILLION)
  • TABLE 147: LATIN AMERICA: APHERESIS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 148: LATIN AMERICA: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 149: NUMBER OF HEMOPHILIA PATIENTS IN BRAZIL: 2012-2015
  • TABLE 150: BRAZIL: APHERESIS MARKET SIZE, BY PROCEDURE, 2014-2021 (USD MILLION)
  • TABLE 151: BRAZIL: APHERESIS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 152: BRAZIL: APHERESIS MARKET SIZE, BY DEVICE TYPE, 2014-2021 (USD MILLION)
  • TABLE 153: BRAZIL: APHERESIS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 154: BRAZIL: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 155: MEXICO: APHERESIS MARKET SIZE, BY PROCEDURE, 2014-2021 (USD MILLION)
  • TABLE 156: MEXICO: APHERESIS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 157: MEXICO: APHERESIS MARKET SIZE, BY DEVICE TYPE, 2014-2021 (USD MILLION)
  • TABLE 158: MEXICO: APHERESIS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 159: MEXICO: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 160: ROLA: APHERESIS MARKET SIZE, BY PROCEDURE, 2014-2021 (USD MILLION)
  • TABLE 161: ROLA: APHERESIS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 162: ROLA: APHERESIS MARKET SIZE, BY DEVICE TYPE, 2014-2021 (USD MILLION)
  • TABLE 163: ROLA: APHERESIS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 164: ROLA: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 165: MIDDLE EAST AND AFRICA: APHERESIS MARKET SIZE, BY PROCEDURE, 2014-2021 (USD MILLION)
  • TABLE 166: MIDDLE EAST AND AFRICA: APHERESIS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 167: MIDDLE EAST AND AFRICA: APHERESIS MARKET SIZE, BY DEVICE TYPE, 2014-2021 (USD MILLION)
  • TABLE 168: MIDDLE EAST AND AFRICA: APHERESIS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 169: MIDDLE EAST AND AFRICA: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 170: AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2016
  • TABLE 171: MERGERS AND ACQUISITIONS, 2012-2015
  • TABLE 172: EXPANSIONS, 2013-2015
  • TABLE 173: PRODUCT LAUNCHES, 2015
  • TABLE 174: OTHER STRATEGIES, 2012-2015

LIST OF FIGURES

  • FIGURE 1: APHERESIS MARKET SEGMENTATION
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BOTTOM-UP APPROACH
  • FIGURE 4: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: GLOBAL APHERESIS MARKET SIZE, BY PROCEDURE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 7: GLOBAL THERAPEUTIC APHERESIS MARKET SIZE, BY DISEASE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 8: GLOBAL THERAPEUTIC APHERESIS MARKET SIZE, BY PROCEDURE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 9: GLOBAL APHERESIS MARKET SIZE, BY PRODUCT, 2016 VS. 2021 (USD MILLION)
  • FIGURE 10: GLOBAL APHERESIS MARKET SIZE, BY DEVICE TYPE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 11: GLOBAL APHERESIS MARKET SIZE, BY APPLICATION, 2016 VS. 2021 (USD MILLION)
  • FIGURE 12: GLOBAL APHERESIS MARKET SIZE, BY TECHNOLOGY, 2016 VS. 2021 (USD MILLION)
  • FIGURE 13: GLOBAL APHERESIS MARKET SIZE, BY CENTRIFUGATION TECHNOLOGY, 2016 VS. 2021 (USD MILLION)
  • FIGURE 14: GEOGRAPHICAL SNAPSHOT OF THE GLOBAL APHERESIS MARKET
  • FIGURE 15: RISING PREVALENCE OF DISEASES AND GROWING NUMBER OF TRAUMA AND INJURY CASES DRIVING THE GROWTH OF THE APHERESIS MARKET
  • FIGURE 16: PLASMAPHERESIS COMMANDED THE LARGEST SHARE IN 2015
  • FIGURE 17: U.S. ACCOUNTED FOR LARGEST SHARE OF THE APHERESIS MARKET IN 2015
  • FIGURE 18: APAC TO GROW AT THE HIGHEST CAGR IN THE FORECAST PERIOD
  • FIGURE 19: DEVELOPING MARKETS TO REGISTER HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 20: APHERESIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
  • FIGURE 21: NUMBER OF PEOPLE WITH CHRONIC CONDITIONS IN THE U.S. (MILLION INDIVIDUALS)
  • FIGURE 22: TYPE OF PLASMA PROCESSED WORLDWIDE, 1996-2012 (THOUSAND LITERS)
  • FIGURE 23: SOURCE PLASMA COLLECTION IN THE U.S. & EUROPE, 2005-2013 (THOUSAND LITERS)
  • FIGURE 24: PORTER'S FIVE FORCES ANALYSIS: APHERESIS MARKET
  • FIGURE 25: THERAPEUTIC APHERESIS, THE FASTEST-GROWING PROCEDURE SEGMENT OF THE APHERESIS MARKET
  • FIGURE 26: DISPOSABLES PRODUCT SEGMENT TO REGISTER HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 27: CENTRIFUGATION SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 28: OTHER APPLICATIONS TO WITNESS HIGHEST GROWTH IN THE APHERESIS MARKET
  • FIGURE 29: GEOGRAPHIC SNAPSHOT: MARKETS IN ASIA-PACIFIC ARE GROWTH HOTSPOTS
  • FIGURE 30: GLOBAL APHERESIS MARKET SHARE, BY REGION, 2015 VS. 2021
  • FIGURE 31: NORTH AMERICA: APHERESIS MARKET SNAPSHOT
  • FIGURE 32: EUROPE: APHERESIS MARKET SNAPSHOT
  • FIGURE 33: APAC: APHERESIS MARKET SNAPSHOT
  • FIGURE 34: AGREEMENTS, COLLABORATIONS, & PARTNERSHIPS, THE MOST-PREFERRED STRATEGIES BETWEEN 2012 AND 2016
  • FIGURE 35: GLOBAL APHERESIS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015
  • FIGURE 36: BATTLE FOR MARKET SHARE: AGREEMENTS, COLLABORATIONS, & PARTNERSHIPS, THE KEY STRATEGIES
  • FIGURE 37: GEOGRAPHIC REVENUE MIX OF MAJOR PLAYERS
  • FIGURE 38: CERUS CORPORATION: COMPANY SNAPSHOT (2015)
  • FIGURE 39: FRESENIUS MEDICAL CARE: COMPANY SNAPSHOT (2015)
  • FIGURE 40: FRESENIUS KABI: COMPANY SNAPSHOT (2015)
  • FIGURE 41: ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2015)
  • FIGURE 42: HAEMONETICS CORPORATION: COMPANY SNAPSHOT (2015)
  • FIGURE 43: TERUMO CORPORATION: COMPANY SNAPSHOT (2015)
  • FIGURE 44: B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2015)
  • FIGURE 45: KANEKA CORPORATION: COMPANY SNAPSHOT (2015)
  • FIGURE 46: KAWASUMI LABORATORIES, INC.: COMPANY SNAPSHOT (2015)
  • FIGURE 47: NIKKISO CO., LTD.: COMPANY SNAPSHOT (2015)
Back to Top